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Background: Blastocystis spp. are one of the most prevalent parasites isolated from patients suffering from diarrhea,
flatulence, constipation and vomiting. It’s pathogenicity and pathophysiology remains controversial to date. Protease
activity and amoebic forms have been reported previously in symptomatic isolates but there has been no conclusive
evidence provided to correlate the protease activity and any specific life cycle stage of the parasite thus far.
Methods: Symptomatic isolates with amoebic form were tested for protease activity and compared with
symptomatic and asymptomatic isolates without amoebic form for 10 days culture period.
Results: The present study demonstrates an elevated protease activity in cultures having a higher percentage of
amoebic forms seen in symptomatic isolates. The growth curve demonstrated a significantly (p < 0.05) higher
average number of parasite counts in asymptomatic compared to symptomatic isolates. Symptomatic isolates
showed amoebic forms with percentages ranging from 5% to 17%. Elevated protease activity was demonstrated in
isolates that had higher percentages of amoebic forms with intense bands at higher molecular weight proteases
(60 – 100 kDa). As days of culture proceeded, the protease quantification also showed a steady increase.
Conclusion: This study elucidates a correlation between protease activity and percentage of amoebic forms.
The finding implies that these forms could play a role in exacerbation of intestinal symptoms during Blastocystis
spp. infection.
Keywords: Blastocystis spp, Protease activity, Amoebic form, GastrointestinalBackground
Blastocystis spp., a controversial anaerobic parasite, has
increasingly gained a reputation for being implicated in
causing flatulence, diarrhea, constipation, vomiting and
skin rash [1-3]. The mechanism of pathogenicity still re-
mains unclear. The prevalence in humans is reported to be
between 0.5% [4] to 60% [5] and 40-60% in animals [2,6].
Genotypic variability has been reported to play an in-
fluential role in the pathogenicity of Blastocystis [7]. This
is evidenced by studies showing Blastocystis subtype 3
being the most common subtype isolated from patients
with various gastrointestinal (GI) disorders. Despite a
few prevalence studies that have been carried out in dif-
ferent countries, which showed subtype 3 followed by
subtype 1 to be the highest [7-10], its pathogenic role
has not been clearly defined. The question of whether* Correspondence: suresh@um.edu.my
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article, unless otherwise stated.there are other factors influencing the parasite in its
ability to be opportunistic in immunocompetent and im-
munocompromised patients [2,11] has not yet been
clearly answered.
There are also reports that demonstrate the lack of
correlation between the symptomatic and asymptomatic
group in terms of genotype distribution [12-14] and
whether this is related to factors such as age of host and
genetics is still uncertain [7]. Amoebic forms, one of the
life cycle stages of the parasite, have been reported to be
present in higher percentages in in vitro cultures of
symptomatic isolates compared to asymptomatic isolates
[15,16]. Previously, amoebic forms were also observed in
colonoscopic lavage and patients with acute diarrheal
syndrome [17,18].
Proteases from Blastocystis spp. have been proven
to be one of the important candidates that contribute
to the pathogenicity of this protozoan parasite [19,20].
Proteases from Blastocystis spp. have been shown toMed Central Ltd. This is an Open Access article distributed under the terms of
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to the parasite’s ability to have greater virulence and
colonization through the elicitation and alteration of im-
munological response as well as the disruption of barrier
function [21-23].
To date there have been no studies to correlate the
presence of amoebic forms in in vitro culture and prote-
ase activity of Blastocystis spp. The present study at-
tempts to elucidate if there is a correlation between the
percentage of amoebic forms in cultures isolated from
asymptomatic and symptomatic patients to protease
activity.
Methods
Source of Blastocystis spp.
Parasites were obtained from random stool sample collec-
tion in a survey carried out in a particular rural area in
Selangor, Malaysia. A total of 5 isolates from symptomatic
(S1-S5) and asymptomatic (A1-A5) patients were continu-
ously cultured in Jones’ medium. The symptomatic isolates
originated from patients showing symptoms such as flatu-
lence, abdominal pain, diarrhea and constipation. ThisFigure 1 Growth profile of Blastocystis spp. isolated from symptomat
number of cells is exhibited.information was obtained using a questionnaire. Samples
with Blastocystis spp. were selected through direct fecal
screening and cyst concentration technique to select the
samples with only Blastocystis spp. as the sole symptom
causative agent.
Culture and purification of Blastocystis spp.
All isolates were inoculated in Jones’ medium sup-
plemented with 10% horse serum as described previously
by Suresh et al. [24]. Cultures were incubated at a con-
stant temperature of 37°C before sub-culturing into fresh
medium once every 3 days. Subsequently, the cells were
purified from bacterial-contaminated culture using density
gradient centrifugation. The cells were pooled into one
tube and washed twice with phosphate buffered saline
(PBS) for 5 minutes at 500 g. Five milliliters of the cell sus-
pension was then layered carefully onto 6 ml of Ficoll-
Paque without agitation. It was then spun for 20 mins at
700 g. Blastocystis spp. cells with minimal bacterial con-
taminants found above the thick layer of yellowish white
clump was then gently isolated and washed with PBS. The
pellet was stored at -20°C until further use.ic (A) and asymptomatic (B) patients. A comparison on the average
Figure 2 Amoebic forms found in in vitro culture of symptomatic (S2) isolates on day 5. Amoebic forms with protruding cytoplasm are
indicated with arrow. Bar = 10 μm.
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in culture
Isolates, maintained for a few weeks and showing con-
sistent growth were used subsequently for the eluci-
dation of morphological forms in culture. 105 cells in
vacuolar form were counted and inoculated into cul-
ture tubes containing 1 ml of Jones’ medium with 10%
horse serum and maintained to determine the growth
profile at 37°C. 10 of culture suspension containing
the parasites was mixed with an equal volume of
Trypan blue to assess cell viability. The isolates were
screened under a light microscope with 40X magnifi-
cation everyday for 10 consecutive days and the per-
centages of amoeboid cells were observed by counting
the number of amoeboid forms in a random count of
100 cells [15]. Parasites from all culture tubes on day 5
were collected, purified and the respective pellets were
then stored at −20°C. In a separate experiment, cell ly-
sates of Blastocystis spp. isolates from all culture tubes
were obtained at different periods of incubation (Day 1,0
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Figure 3 Percentage of amoeboid forms in symptomatic isolates over
medium supplemented with 10% horse serum at 37C. Note: Initial culture3, 5 and 7), which were then subjected to the Gelatin-
SDS-PAGE and azocasein assays for the detection of pro-
tease activity using a standardized protein concentration
of 0.1 mg/ml.
Gelatin-SDS-PAGE for the detection of protease activity
Purified isolates were washed twice with 0.85% NaCl.
The respective pellets were then re-suspended with 200
of lysis buffer containing 4.3 g of sucrose and 100 mM
of NaCl in 1% triton-X and kept overnight at 4°C. Pro-
tein concentration was then estimated using the Bio-Rad
Microassay method (Bio-Rad). Twelve percent of resolv-
ing and 5% of stacking gel were prepared. Cell lysates
with standardized protein concentration were then electro-
phoresed as described previously [20]. The gel was then
subjected to re-naturation and incubation to observe the
protease activity. Subsequently, the gel was stained with
0.12% (w/v) Coomassie Brilliant Blue R-250 for 1 hour.
The protease bands appear as colorless bands with a dark
blue background.S1
S2
S3
S4
S5
a 10 days growth period. All isolates were inoculated in Jones
volume was 105 cells/ml.
S1 S2 S3 S4 S5 A1 A2 A3 A4 A5M
60 kDa –
100 kDa –
75 kDa –
Figure 4 Protease profile from the cell lysates of symptomatic isolates (S1-S5) and asymptomatic isolates (A1-A5) of Blastocystis spp.
The concentration of the cell lysate was standardized (0.1 mg/ml) and the lysates of each isolate was harvested on day 5 of incubation at 37C.
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of protease activity
Parasites were purified as described previously. The cells
were lysed through a series of 15 cycles of freeze and
thaw. The tubes containing the respective pellets were
stored at 4°C overnight. The contents of each tube were
centrifuged to sediment the debris and the protein content
was estimated using the Bio-Rad Microassay method
(Bio-Rad). The concentration of each sample was stan-
dardized before the assay. The cell lysates were initially in-
cubated for 10 minutes with the supplementation of DTT
(2 mM) (Sigma-Aldrich) at 37°C. This activated the para-
sitic proteases. 5 mg/ml of Azocasein was prepared in PBS
at pH 7.4. One hundred microliters of lysate was mixed
with 100 of pre-heated (37°C) azocasein solution and left0
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Figure 5 Protease activity of symptomatic (S1-S5) and asymptomatic
concentration of cell lysate was standardized to 0.1 mg/ml. Values are obta
triplicates in each samples and standard deviations are indicated as error bto incubate at 37°C for 1 hour. The reaction was stopped
by the addition of 300 of ice-cold Trichloroacetic acid and
the mixture was then left on ice for 30 minutes. The tubes
were then centrifuged at 8000 g to remove the undigested
azocasein and the supernant was subsequently added to
500 of NaCl (500 mM). The clear orange solution that was
produced was measured at 440 nm absorbance. Trypsin
and inactivated lysate were used as positive and negative
controls respectively. This experiment was carried out
in triplicate.
Statistical analysis
All statistical analysis was carried out using IBM© SPSS©
Statistics Version 21. Independent Students t-test was
used to assess the difference in the number of cells and(A1-A5) isolates of Blastocystis spp. on day 5 of incubation. The
ined from an average of three independent experiments with
ars.
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amoebic forms, symptomatic isolates without amoebic
forms and asymptomatic isolates. Pearson Correlation Test
was used to assess the correlation between protease activity
and percentage of amoebic forms. A value of p < 0.05 is
considered statistically significant.75  kDa –
M D1
M D1
M D1
60 kDa –
100 kDa –
Figure 6 Gelatin-SDS PAGE for protease activity of Blastocystis spp. is
(A) Symptomatic isolates with amoebic form. (B) Symptomatic isolate with
almost no bands observed. A standard protein marker was used for all threResults
Growth profile studies were carried out in all five symp-
tomatic and asymptomatic isolates respectively over a
10 day period. The growth profile of both symptom-
atic and asymptomatic isolates for a 10 day culture
period showed significantly (p = 0.008) higher peak parasiteB
D3 D5 D7
D3 D5 D7
D3 D5 D7
A
C
olate at 4 different culture days (D1, D3, D5 and D7).
out the presence of amoebic form. (C) Asymptomatic isolates with
e experiments.
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(Figure 1). All symptomatic isolates (S1 to S5) showed
amoebic forms over the 10 day culture period with a size
range between 2.9 – 8.0 μm (Figure 2). Amoebic forms
were first observed on day 3 with cells showing multiple
extended irregular shaped cytoplasm and a prominent nu-
cleus. These forms persisted until day 7 (S1, S3 and S5) to
day 8 (S2 and S4) with the percentage ranging from 5% to
17% (Figure 3). Higher percentages of amoebic form were
observed in S2 (18%) followed by S1 and S5, which was
16% and 11% respectively. S3 and S4 showed the least
number of amoebic forms. Asymptomatic isolates showed
no amoebic forms in culture but had a higher parasite
count with forms being mostly vacuolar followed by granu-
lar (data not shown).
Protease activity using the azocasein assay and gelatin-
SDS-PAGE demonstrated higher activity in symptomatic
isolates with the highest observed in S2 followed by S1,
S5, S4 and S3. Asymptomatic isolates demonstrated a
consistently lower activity of protease in all five isolates.
Elevated protease activity was demonstrated in isolates
that exhibited higher percentages of amoebic forms with
intense bands (Figure 4). The variation in the intensity of
the band was observed only with higher molecular weight
proteases (60 – 100 kDa). Protease banding patterns in
current protease zymography showed a similar outcome as
in the azocasein assay (Figure 5). The bands were more in-
tense in S1, and S2 whereas the bands in S3, S4 and S5
showed less intense bands. However, only high molecular
weight protease bands were observed to correlate with the
percentage of amoebic forms seen in culture. Lower mo-
lecular weight protease did not show much correlation and
an intense band was seen only in isolate S4 at 28–17 kDa.
As days of culture preceded the protease quantifica-
tion (Figure 6) also showed a steady increase in the0
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Figure 7 Protease activity at 4 different points of incubation. Trypsin w
negative control. Values were obtained from an average of three independ
deviations are indicated as error bars.band intensity until day 5 with a slight decrease observed
only on day 7. Apparently, there was no obvious variation
in the band intensity observed in symptomatic isolates
without amoebic forms. A similar outcome was observed
for asymptomatic isolates with only very faint bands spot-
ted for all 4 different incubation days. A similar lysate con-
centration of symptomatic isolates with amoebic forms,
symptomatic isolates without amoebic forms and asymp-
tomatic isolates were used for the azocasein assay Figure 7.
The results showed almost equal increases in protease ac-
tivity on days 1, 3, 5 and 7 of the culture period. However,
protease activity of symptomatic isolates with amoebic
forms was significantly higher than the rest.
Symptomatic isolates with amoebic forms showed sig-
nificantly higher activity of protease compared to symp-
tomatic isolates without amoebic forms (p = 0.014) and
asymptomatic isolates (p = 0.003). Furthermore, a strong
correlation between the percentage of amoebic forms
and average protease activity was observed (Table 1).
Discussion and conclusions
This study is the first to report a correlation between the
presence of amoebic forms and protease activity of
Blastocystis spp. Proteases have previously been shown to
be involved as one of the pathogenic factors of Entamoeba
histolytica, Trichomonas vaginalis and Acanthamoeba sp.
[25-27]. In a previous study on Blastocystis spp., subtype 3
of symptomatic isolates were shown to frequently posses
protease activity especially at 32 kDa, which was postu-
lated to be the virulent factor [20].
Cysteine-type activity of protease was observed in
Blastocystis spp. isolated from patients with gastro-
intestinal symptoms [19] with its effect on intestinal cells
and gut functions [28]. Proteases from Blastocystis spp.
have also been shown to cleave intestinal IgA and elicititive
ntrol
Negative
Control
Asymptomatic
Symptomatic Non-amoebic
Symptomatic Amoebic
Controls
as used as positive control and heat-inactivated lysate was used as
ent experiments with triplicates in each sample and standard
Table 1 Pearson’s correlation of average protease activity
and average amoebic form count
p Correlation
coefficient(r)
Protease activity and amoebic cell count 0.036 0.964
Very high correlation is observed with significance level at p < 0.05.
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not attempt to provide credible evidence on the life cycle
stage of Blastocystis spp. responsible for protease activity.
The relationship of proteases to pathogenicity can be
better illustrated with the example of Entamoeba histo-
lytica where its membrane-associated serine proteases,
with a molecular weight 60 kDa, were shown to be re-
sponsible for the degradation lysosamal proteins and tight
junctions in target cells. These proteases were found in
low levels in the non-pathogenic strain, Entamoeba dispar
[29]. Proteases from Trypanosoma cruzi [30] and Acanth-
amoeba [31] have been shown to play a role in immune
evasion during Chagas disease and be responsible for
extracellular membrane degradation during granuloma-
tous encephalitis respectively.
Amoebic forms were shown to be a life cycle stage of
Blastocystis spp. [32] as well as being seen in cultures
isolated from symptomatic patients [16,32,33]. Amoebic
forms have also been reported in stool specimens of pa-
tients with diarrhea [34]. In the present study we also saw
amoebic forms only in symptomatic isolates. Amoebic
forms have been shown to be responsible for the engulf-
ment of bacteria [32] which could then survive and repli-
cate within lysosomes or phagosomes [35]. Whether
bacteria contribute to the pathogenic role of the parasite
still remains in question.
The present study demonstrated intense protease ac-
tivity seen on day 5 in all symptomatic isolates, which0
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Figure 8 Assessment of bacterial contamination in cell lysates of Blas
bacterial contaminant in cell lysate.correspondingly co-related to the intense bands of 60–
100 kDa seen in the same day having the higher percent-
age of amoebic forms observed in all isolates. The pres-
ence of lower molecular weight (17 – 28 kDa) protease
in isolates S2 and S4 as well as in asymptomatic isolates
(A1 and A3) elicits a question on the significance of this
band, which remains unclear although lower molecular
weight bands in other studies have been suggested to be
a virulence factor [19,20].
Moreover, our study suggests a steady increase in pro-
tease activity during the incubation corresponding to an
increase in amoebic forms and a slight decrease on day
7, which relates to the drop in amoebic forms. A previ-
ous study reported that the fluctuation of cell size and
protease activity appears to have a strong correlation
when examined over a 96 hour incubation period [23].
This study contradicts our observation in that other than
the percentage of amoebic forms, size of cell showed no
influence on the protease activity. The present study in-
volved a painstaking and tedious process to screen large
samples of stools to obtain Blastocystis infected stool
samples. We limited the study to a sample size of 5 as
we had to obtain positive stool samples from symptom-
atic and asymptomatic patients, given that other pub-
lished papers relating protease activity and Blastocystis
spp. as well as other parasites have been carried out on a
smaller sample size yet demonstrated, as in our study,
significant and consistent results [19,21,27,36]. Similar
studies should be carried out with larger sample sizes
with isolates that have undergone genotypic characte-
rization to statistically concrete our postulation and to
completely understand the variation of protease activity
in different life cycle stages of Blastocystis spp.
Our axenization attempts purified the parasite with
minimal bacterial concentration. In the present study,ysate Bacteria
tocystis spp. used in this study. Graph shows the protease activity of
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lates. This was thought to mimic an environment similar
to the natural intestinal microflora [15]. We have also
shown that cell lysates with bacterial proteins had min-
imal effect since the bacterial protein demonstrated min-
imal protease activity (Figure 8).
The peak parasite count (parasite count between day
5 – 7) was used as one of the parameters in a previ-
ous study to differentiate the phenotypic characteristics
of Blastocystis spp. It has been reported that asymptomatic
isolates grew faster and the average total number of cells
reached up to 7 times more than symptomatic isolate. The
generation time was twice as high in asymptomatic iso-
lates [37]. The present study concurred with these findings
in that the asymptomatic isolates showed higher parasite
peak counts than symptomatic ones (Figure 2). It is there-
fore evident that protease activity did not arise despite the
higher parasite count consisting of mostly vacuolar and
granular forms seen in asymptomatic isolates but from the
larger percentage of amoebic forms seen in symptomatic
isolates.
The amoebic form of Blastocystis spp. has been postu-
lated previously to posses a sticky surface, which en-
hances the adherence to the intestinal epithelial cell
lining [16]. This adherence could facilitate the release of
proteases from amoebic forms to degrade extracellular
membrane similar to that as seen in Entamoeba histolytica
[38]. Higher occurrence of Blastocystis spp. has been seen
in cancer patients undergoing chemotherapy [39]. Exacer-
bation of symptoms in such situations could be attributed
to vacuolar stages reverting to amoebic forms, which in
turn could be causing the related symptoms due to the re-
lease of proteases.
In conclusion, this is the first study to provide evi-
dence co-relating amoebic forms of Blastocystis spp. and
protease activity, which suggests a strong pathophysio-
logical role that amoebic forms can play in exacerbating
symptoms in patients infected with Blastocystis spp.
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